Nuvaring News

Women in the United States who have experienced a PE or DVT are considering becoming part of a Nuvaring class action lawsuit.

Significant questions of late have arisen with regards to the Nuvaring labels. Concern is that sufficient notice has not been provided that warns women of the risk of pulmonary embolism (PE), deep vein thrombosis (DVT) and additional related health conditions including stroke. As follows, a press release provided by the Office of Public Health and Science emphasizes blood clots and their potential for life-threatening risks.

A Call to Action is issued to Prevent Pulmonary Embolism and Deep Vein Thrombosis

Steven K. Galson, M.D., M.P.H., is Acting Surgeon General. He today put forth a Call to Action to decrease the number of medical cases involving pulmonary embolism and deep vein thrombosis across the United States.

Galson encouraged every American to educate themselves and avert such treatable conditions.

Pulmonary embolism and deep vein thrombosis impact some 350,000 to 600,000 Americans every year. It is anticipated that those numbers will rise as the population ages. Combined, pulmonary embolism and deep vein thrombosis are accountable for more than 100,000 deaths every year.

A blood clot that is within a deep vein, typically in the thigh or lower leg, is deep vein thrombosis. Such a clot can restrict blood and create skin discoloration, swelling and pain. In the most severe cases, this condition can cause a pulmonary embolism. This occurs when a portion of the blood clot falls loose and moves via the bloodstream into the lungs. The clot can then block an artery of a lung, thus damaging the lungs or additional vital organs as a result of lost oxygen.

Galson stated that pulmonary embolism and deep vein thrombosis both are typically “silent” conditions. Either can happen without symptoms, taking patients unaware. He further indicated that much progress have been made in understanding the disorders. Medical professionals now have knowledge on preventing, diagnosing and treating them. Such knowledge needs to be put “into action.”

Researchers have discovered that with a number of cases, pulmonary embolism and deep vein thrombosis occur in persons with an inherited disorder that inhibits blood clotting. Additional risk factors also exist, as do events that simply trigger the conditions.

Galson indicated that hospitalization, bed rest confinement, undergoing major surgery, traumatic occurrences, and traveling for multiple hours can add to a person’s chances of developing pulmonary embolism and deep vein thrombosis. He and other medical professionals desire to increase peoples’ awareness and knowledge of such life-threatening conditions. They also wish to encourage both patients and health care professional to act in ways that “prevent them.”

The Call to Action encourages a comprehensive and multifaceted strategy to decrease nationwide the amount of cases of pulmonary embolism and deep vein thrombosis. The strategy stresses the need for:

• Heightened awareness regarding pulmonary embolism and deep vein thrombosis.
• Verification-based treatments for deep vein thrombosis.
• Increased research for the sources, deterrence and therapy of deep vein thrombosis.

A Surgeon General’s Workshop on Deep Vein Thrombosis resulted in the Call to Action. The workshop assembled in May, 2006. The National Heart, Lung, and Blood Institute (NHLBI) co-sponsored the workshop.

Elizabeth G. Nabel, M.D. is the Director of the NHLBI. She noted that pulmonary embolism and deep vein thrombosis both are significant public health dilemmas. The NHLBI has pledged to further support all research efforts that advance peoples’ comprehension of the debilitating and life-threatening risks posed by such conditions. She added that new research helps bring to the forefront those factors that heighten a person’s risk for getting precarious blood clots. Medical professionals and experts of public health must collaborate to utilize scientific evidence “to save lives.”

The Call to Action was contributed to by The Agency for Healthcare Research and Quality (AHRQ) by releasing two new informative guides that explain preventive measures for precarious blood clots. One guide is aimed at patients, and the other is for providers of health care. Carolyn M. Clancy, M.D., is the Director for the AHRQ. She indicated that fighting the conditions of pulmonary embolism and deep vein thrombosis requires team efforts. Patients and providers of health care must work alike.

We are representatives of all women who suffer Nuvaring side effects. We work on the basis of a contingency, meaning no legal fees are paid unless your case wins compensations. Please call our toll free number for a free no-obligation consultation. You can also complete a short contact form available online, and a Nuvaring class action lawsuit attorney will contact you. We are available to provide answers to all of your questions.

Nuvaring Side Effects | Nuvaring Lawsuit Attorney

A majority of woman who have a used a form of birth control known as Nuvaring birth control, have later developed a blood clot. When a woman has developed this clot they later get prescribed a blood thinner like Lovenox or Coumadin. Coumadin can have a side effect of abnormal bleeding. For 3 to 6 months the woman takes their prescription blood thinner after the diagnosis of a DVT or pulmonary embolism.

Coumadin, also known as warfarin, is one of the most common anticoagulant. It works by helping decrease the amount of vitamin K within the body thusly reducing the chance of a blood clot. A blood clot poses a serious threat to any because it cuts off the circulation of blood to a certain part of the body. Coumadin doesn’t get rid of blood clots that have already formed but it does not allow current ones to grow larger or allow any new ones to grow at all. Clots can develop anywhere within the body. The most dangerous areas for a clot to be include the veins of the brain and upper extremities as well as superficial veins of extremities.

The prescription of Coumadin is usually issued if you have forming blood clots, otherwise known as venous thrombosis, or have been diagnosed with an illness that can form blood clots. Conditions that can drastically raise the risks of getting a blood clot include a recent heart attack, heart surgeries and a type of irregular heart beat. Some, but not all women, who have used a Nuva ring as a contraceptive, have developed a pulmonary embolism or DVT.

Different tests are performed on your blood pressure to help determine the doses in which you should be prescribed. The doses vary from 1 to 10mg and these rounded tablets are to be taken once a day whether they are taken with food or without food.

Coumadin, though a good drug that can save lives, also poses the chances of serious side effects that can cause abnormal and sometimes in a worst case scenario serious profuse bleeding. When taking Coumadin the user must pay attention to their stool and if it because tarry-appearing or black then they must seek medical attention right away. Easy bruising can occur anywhere on the body. Some foods can cross negatively with this drug; foods that contain a lot of vitamin K can interrupt the process of Coumadin and leave the patient with a high chance of having a stroke. Always talk to your body before taking this medication and be sure to give a complete list of the medications that you are currently taking and a complete health history of you and your family. Other side effects include irregular swelling of your face and limbs, chest pain and pressure, vomiting, nausea, fever, diarrhea, difficulty moving and tingling or numbness of the body.

If you are suffering from a Nuvaring blood clot then we will represent you with absolutely no legal fees unless compensation is won by us in your case. Please fill out our no-obligation contact form online or give us a call for one of our Nuvaring lawyers to contact you to answer any and all questions you may have about Coumadin.

Contact the McEwen Law Firm today at (800) 732-3070 to discuss your case and receive compensation you deserve!

Nuvaring Problems | Nuvaring Side Effects Lawyer

The NuvaRing side effects would be including strokes, heart attacks and blood clots had been reported by the women that have been using the NuvaRing all around the US. Many of these women who had suffered the side effects of the NuvaRing had filed the Nuvaring lawsuit that had been based upon the arguments that this ring would increase the risks of developing the life threatening clot.

Some of the third generation contraceptives have been associated with the hormones which can might change in your blood clotting system that allows the blood clots to begin to form easily. This birth control ring had been approved by FDA back in October 3rd, 2001 and had first been marketed in the US back in July of 2002. The NuvaRing has been used by about 1,000,000 women worldwide.

Following recent Supreme Court decisions made in Wyeth v. Levine, the attorneys for the manufacturers of the Nuvaring had withdrew their motions for the summary judgments they had been filed back in November of 2008. These motions had been arguing that the manufacturers should be totally protected from the state product liabilities Nuvaring lawsuits since the FDA had approved Nuvaring’s warning labels. Plaintiff’s who have brought the Nuvaring lawsuits had claimed that this birth control ring had failed to warn the consumers about the risks of having blood clots for.

We have represented all the women that have been suffering from the Nuvaring side effects right on the contingency basis, this is meaning that there would never be any fees unless would would wind the compensation for you in your case. For your no-obligation and free consultation call us toll free or you could fill the very short online form out and the Nuvaring lawsuit lawyers would contact you so you could get the answers you are needing.

Contact the McEwen Law Firm today about this lawsuit at (800) 732-3070 if you have been injured by Nuvaring.